Biotechnology

Genetic Engineering Drug Development Genetics Pharmaceuticals Nanotechnology Gene Therapy Vaccine Development Gene Editing Research and Development Genomics

5 ARTICLES

yesterday

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

An interim analysis showed improved recurrence-free and distant-metastasis-free survival with no new safety signals, and the companies plan to release full data and begin regulatory discussions.

5 ARTICLES

3d ago

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

119 ARTICLES

3d ago

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

4 ARTICLES

5d ago

Genome-Wide CRISPR Screen Identifies Two Human Genes That Boost Nonviral Editing

3 ARTICLES

last wk.

Engineered PRAME T Cells Produce One-Year Remission in Teen With Metastatic Kidney Cancer

3 ARTICLES

last wk.

MethylScan Blood Test Detects Multiple Cancers and Classifies Liver Disease

3 ARTICLES

2w ago

Scientists Produce Two Beagles Lacking the Main Dog Allergen

3 ARTICLES

2w ago

MiNK Reports Early Phase 2 Day‑28 Survival and Clinical Signals for Off‑the‑Shelf iNKT Therapy

6 ARTICLES

2w ago

Scientists Engineered Lettuce and Tobacco to Make Animal Muscle Protein

5 ARTICLES

2w ago

Researchers Use CRISPR to Remove Major Dog Allergen in Two Beagles

3 ARTICLES

2w ago

Genentech Moves First AI‑Discovered Neuroscience Target Into Joint Discovery With Recursion

3 ARTICLES

2w ago

LMU Team Creates Reproducible 3D Human Brain Spheroid That Models Alzheimer’s

6 ARTICLES

3w ago

Journal and University Open Investigations After Child’s Death Linked to Brain-Targeted Gene Editing

3 ARTICLES

3w ago

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

3 ARTICLES

3w ago

FDA Grants Fast Track to Insilico’s AI‑Designed Mesothelioma Drug Candidate

3 ARTICLES

3w ago

Researcher Investigated for Concealing Child’s Death After Experimental Gene‑Editing Trial

Biotechnology

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

BioMarin to Buy Alesta for $275 Million to Add Oral HPP Drug

Fulcrum Agrees to Merge With Slate Medicines, Plans Nasdaq Relaunch as SLTE

Sandoz Signs Exclusive Deal to Commercialize Up to 10 Henlius Biosimilars

AI Designs Functional Bacteriophages in Laboratory Tests

Genome-Wide CRISPR Screen Identifies Two Human Genes That Boost Nonviral Editing

Engineered PRAME T Cells Produce One-Year Remission in Teen With Metastatic Kidney Cancer

MethylScan Blood Test Detects Multiple Cancers and Classifies Liver Disease

Never miss stories about

Biotechnology

Scientists Produce Two Beagles Lacking the Main Dog Allergen

MiNK Reports Early Phase 2 Day‑28 Survival and Clinical Signals for Off‑the‑Shelf iNKT Therapy

Scientists Engineered Lettuce and Tobacco to Make Animal Muscle Protein

Researchers Use CRISPR to Remove Major Dog Allergen in Two Beagles

Genentech Moves First AI‑Discovered Neuroscience Target Into Joint Discovery With Recursion

LMU Team Creates Reproducible 3D Human Brain Spheroid That Models Alzheimer’s

Journal and University Open Investigations After Child’s Death Linked to Brain-Targeted Gene Editing

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

FDA Grants Fast Track to Insilico’s AI‑Designed Mesothelioma Drug Candidate

Researcher Investigated for Concealing Child’s Death After Experimental Gene‑Editing Trial

Never miss stories about

Biotechnology